CGRP Therapies May Reduce Migraine Days - Poll - MDSpire

CGRP Therapies May Reduce Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies.

By
Andrea Surnit
May 20, 2026
3 min

MDSpire News

Share

Original Source(s)

Mdspire News

CGRP Therapies May Reduce Migraine Days

by Andrea Surnit
May 20, 2026

Related Content

Frontiers In Neurology

Headache service quality in Egypt: current status, identified gaps, and strategic directions

by Amr Hassan, Mona Hussein, Rehab Magdy, Derya Uludüz, Aynur Özge, Semih Taşdelen, Sarkhan Amirguliyev, Tayyar Şaşmaz, Mohamad Osama Abdulghani, Ramez Reda Moustafa, Ahmed Essmat, Osama Yacoub, Mohamed Abdelghaffar, Nourhan Abdelmohsen Taha, Anas Elgenidi, Nahla Merghany, Sherien Mohamed Farag, May M. Fayez, Doaa Mahmoud Khalil, Rami Burstein
July 2, 2026

Frontiers In Pain Research

Combined bidirectional spinal cord stimulation for refractory neuropathic pelvic pain: a case report

by Yakov Perper, Alana Taub, Jenifer Perper
July 1, 2026

Journal Of Medical Internet Research (Jmir)

Potential of Digital Tools for Chronic Pain Management

by Vanessa Nirode
June 22, 2026